Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Lactulose30 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A01966 | 34549558 | Adv Clin Exp Med | A novel therapeutic approach to NASH: Both polyethylene glycol 3350 and lactulose reduce hepatic inflammation in C57BL/6J mice. | 2021 | Details |
| A03776 | 33867442 | Eur J Gastroenterol Hepatol | Small intestinal bacterial overgrowth and orocecal transit time in patients of nonalcoholic fatty liver disease. | 2021 | Details |
| A05228 | 33331479 | Arq Gastroenterol | PERIPHERAL BLOOD ENDOTOXIN LEVELS ARE NOT ASSOCIATED WITH SMALL INTESTINAL BACTERIAL OVERGROWTH IN NONALCOHOLIC FATTY LIVER DISEASE WITHOUT CIRRHOSIS. | 2021 | Details |
| A06232 | 32961235 | Life Sci | Liraglutide modulates gut microbiome and attenuates nonalcoholic fatty liver in db/db mice. | 2020 | Details |
| A07112 | 32618656 | Am J Gastroenterol | Allogenic Fecal Microbiota Transplantation in Patients With Nonalcoholic Fatty Liver Disease Improves Abnormal Small Intestinal Permeability: A Randomized Control Trial. | 2020 | Details |
| A07485 | 32476788 | World J Gastroenterol | Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care. | 2020 | Details |
| A07754 | 32363684 | Aliment Pharmacol Ther | Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis. | 2020 | Details |
| A08189 | 32213035 | United European Gastroenterol J | Clinical management of type C hepatic encephalopathy. | 2020 | Details |
| A09183 | 31845776 | Am Fam Physician | Cirrhosis: Diagnosis and Management. | 2019 | Details |
| A14029 | 29627620 | Contemp Clin Trials | Efficacy, safety, and tolerability of lubiprostone for the treatment of non-alcoholic fatty liver disease in adult patients with constipation: The LUBIPRONE, double-blind, randomised, placebo-controlled study design. | 2018 | Details |
| A16459 | 28375406 | J Fam Pract | Hot Topics in Primary Care: Diagnosis of Cirrhosis and Evaluation of Hepatic Encephalopathy: Common Errors and Their Significance for the PCP. | 2017 | Details |
| A18073 | 27367724 | Nutrients | Beneficial Effect of Synbiotic Supplementation on Hepatic Steatosis and Anthropometric Parameters, But Not on Gut Permeability in a Population with Nonalcoholic Steatohepatitis. | 2016 | Details |
| A18103 | 27350543 | Pediatr Obes | Multiple gut-liver axis abnormalities in children with obesity with and without hepatic involvement. | 2016 | Details |
| A18939 | 26858714 | Front Microbiol | Ethanol Production by Selected Intestinal Microorganisms and Lactic Acid Bacteria Growing under Different Nutritional Conditions. | 2016 | Details |
| A22376 | 24631029 | Dig Liver Dis | Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. | 2014 | Details |
| A28210 | 16124065 | World J Gastroenterol | Effect of lactulose on establishment of a rat non-alcoholic steatohepatitis model. | 2005 | Details |
| A28241 | 15986870 | Dig Dis Sci | Increased orocecal transit time in patients with nonalcoholic fatty liver disease. | 2005 | Details |
| A29097 | 34567473 | J Community Hosp Intern Med Perspect | Identifying areas of improvement in nursing knowledge regarding hepatic encephalopathy management. | 2021 | Details |
| A35342 | 21046243 | Dig Dis Sci | Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. | 2010 | Details |
| A36345 | 18397235 | Liver Int | Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis. | 2008 | Details |
| A36852 | 17085338 | Hepatobiliary Pancreat Dis Int | Cisapride decreasing orocecal transit time in patients with nonalcoholic steatohepatitis. | 2006 | Details |
| A43276 | 32087105 | Am J Med | A Confusing Picture: Refractory Encephalopathy Complicating Nonalcoholic Steatohepatitis. | 2020 | Details |
| A45878 | 22230269 | Am Fam Physician | Cirrhosis: diagnosis, management, and prevention. | 2011 | Details |
| A45954 | 21885692 | Cleve Clin J Med | Hepatic encephalopathy: suspect it early in patients with cirrhosis. | 2011 | Details |
| A46144 | 20731092 | Voen Med Zh | [Condition of the intestinal tract microbiocenosis in patients with nonalcoholic fatty liver disease and the methods of its correction]. | 2010 | Details |
| A48907 | 24824124 | Zhonghua Gan Zang Bing Za Zhi | [TLR4 contributes to intestinal hyperpermeability in alcoholic liver disease]. | 2014 | Details |
| A49233 | 35814507 | J Clin Exp Hepatol | Demonstration of Gut-Barrier Dysfunction in Early Stages of Non-alcoholic Fatty Liver Disease: A Proof-Of-Concept Study. | 2022 | Details |
| A49812 | 35629938 | Metabolites | Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability. | 2022 | Details |
| A50025 | 35559337 | Front Med (Lausanne) | The Apparent Asymmetrical Relationship Between Small Bowel Bacterial Overgrowth, Endotoxemia, and Liver Steatosis and Fibrosis in Cirrhotic and Non-Cirrhotic Patients: A Single-Center Pilot Study. | 2022 | Details |
| A52374 | 28049662 | Am J Clin Nutr | Gut permeability is related to body weight, fatty liver disease, and insulin resistance in obese individuals undergoing weight reduction. | 2016 | Details |